SCHEMBL4960071

SCHEMBL4960071

N#Cc1c(NC(=O)C2CC2c2cccc(Cl)c2)sc2c1CCNC2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
ALDH1A1 P00352 6/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 3/20 0.41
POLB P06746 2/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PLA2G1B P04054 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
LPAR2 Q9HBW0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961190 0.89 SMN1; SMN2 (0.48) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL4961200 0.89 ALDH1A1 (0.41) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL2894559 0.89 ALDH1A1 (0.47) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL4964184 0.87 ALDH1A1 (0.41) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL2891422 0.87 ALDH1A1 (0.47) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL4771546 0.85 NPC1 (0.45) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL2887971 0.84 LMNA (0.48) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL4961167 0.84 ALDH1A1 (0.45) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL4961044 0.83 ALDH1A1 (0.48) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL4964396 0.83 MAPK10 (0.46) ALDH1A1MEN1MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896484-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-12 EP disclosed
WO-2006125813-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed